NHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Beijing Center for Disease Control and Prevention, Beijing, People's Republic of China.
PLoS One. 2019 Jun 20;14(6):e0218782. doi: 10.1371/journal.pone.0218782. eCollection 2019.
Due to the Expanded Program on Immunization (EPI) and supplementary immunization activities (SIAs) in China, the incidence of measles in China has decreased extensively. The incidence reached its lowest levels in contemporary history in 2012 and 2017, with incidence rates of 4.6 and 4.3 per million population, respectively. However, more than 147,000 measles cases were reported from 2013 to 2016. Furthermore, the proportions of cases in infants < 8 months and adults have been increasing since 2013, representing a considerable challenge for measles elimination in China. A total of 14,868 measles viruses were isolated from confirmed measles cases from 2011 to 2017, of which 14,631 were identified as the predominant endemic genotype, H1; 87 were identified as genotype A viruses that were vaccine associated strains; and 150 were identified as non-H1 genotype viruses. The non-H1 genotype viruses included 62 D8 viruses, 70 D9 viruses, 3 D11 viruses, 14 B3 viruses, and 1 G3 virus, which were identified as imported or import-related viruses that caused sporadic cases or small outbreaks. Most of the transmission chains detected during the period 2011-2012 were interrupted and were followed by many new transmission chains of unknown origin that spread, causing a large measles resurgence in China during 2013-2016. After 4 years of measles resurgence and continuous implementation of the routine immunization program and SIAs, the population immunity reached a sufficiently high level to interrupt most of the transmission chains; only a few strains survived, which continued to be sporadically detected in China in 2017. In the present study, the results from the combined epidemiological and molecular virological data demonstrated the great progress towards measles elimination in China by the further analysis of circulation dynamics for the endemic H1 genotype measles virus from 2011 to 2017. And this study accumulated critical baseline data on circulating wild-type measles viruses in China and provides comprehensive information to the world. These comprehensive baseline data provide evidence to support measles elimination in the future, not only in China but also in other countries worldwide. In addition, the information will be very useful to other countries for tracing their sources of measles cases and for identifying transmission links, which can help prevent potential measles outbreaks.
由于中国的扩大免疫规划(EPI)和补充免疫活动(SIAs),麻疹在中国的发病率已大幅下降。2012 年和 2017 年的发病率达到了历史最低水平,分别为每百万人 4.6 例和 4.3 例。然而,2013 年至 2016 年期间报告了超过 147,000 例麻疹病例。此外,自 2013 年以来,8 个月以下婴儿和成年人病例的比例一直在增加,这对中国消除麻疹带来了相当大的挑战。2011 年至 2017 年期间从确诊麻疹病例中分离出了 14,868 株麻疹病毒,其中 14,631 株鉴定为主要地方性基因型 H1;87 株鉴定为疫苗相关的 A 基因型病毒;150 株鉴定为非 H1 基因型病毒。非 H1 基因型病毒包括 62 株 D8 病毒、70 株 D9 病毒、3 株 D11 病毒、14 株 B3 病毒和 1 株 G3 病毒,这些病毒被鉴定为输入或输入相关病毒,引起散发病例或小暴发。2011-2012 年期间检测到的大多数传播链都被中断,随后出现了许多新的、来源不明的传播链,导致 2013-2016 年中国麻疹疫情大规模反弹。麻疹疫情反弹 4 年后,常规免疫规划和补充免疫活动的持续实施使人群免疫力达到了足以中断大多数传播链的较高水平;只有少数毒株存活下来,并在 2017 年继续在中国零星检出。本研究结合了流行病学和分子病毒学数据,通过进一步分析 2011-2017 年地方性 H1 基因型麻疹病毒的传播动态,证明了中国在消除麻疹方面取得了巨大进展。本研究积累了中国野生型麻疹病毒流行的关键基线数据,为全球提供了全面信息。这些综合基线数据为未来在中国乃至全球其他国家消除麻疹提供了证据支持。此外,这些信息对其他国家追查麻疹病例来源和识别传播环节非常有用,有助于预防潜在的麻疹暴发。